BioXcel Therapeutics Inc (NASDAQ:BTAI) traded at $2.47 at close of the session on Tuesday, March 11 and made a downward move of -16.84% on its previous day’s price. BioXcel Therapeutics Inc has a market cap of $8.13 million and is expected to release its quarterly
BioXcel Therapeutics Inc (NASDAQ:BTAI) shares, rose in value, with the stock price up by 13.87% to the previous day’s close as strong demand from buyers drove the stock to $3.12. Actively observing the price movement in the recent trading, the stock is buoying the session
The trading price of BioXcel Therapeutics Inc (NASDAQ:BTAI) closed lower on Tuesday, March 04, and closing at $2.70, -28.00% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $52.80 and a 52-week low
BioXcel Therapeutics Inc (NASDAQ:BTAI) price closed lower on Tuesday, February 04, and dropping -7.38% below its previous close. A look at the daily price movement shows that the last close reads $0.31, with intraday deals fluctuated between $0.284 and $0.33. The company’s 5Y monthly beta
BioXcel Therapeutics Inc (NASDAQ:BTAI) concluded the trading at $0.33 on Friday, January 31 with a rise of 0.96% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.32 and 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
